How did UTHR's revenue and expenses trend in Q4 2024?

United Therapeutics Corporation (UTHR) demonstrated robust revenue growth in Q4 2024, but reported no expenses data for the quarter. 1. **Revenue Trend**: UTHR's total revenue for Q4 2024, was $735.9 million. This indicates a strong financial performance, especially when compared to the previous year's revenue. |code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code| |---|---|---|---|---|---|---| |UTHR|UTHR.O|United Therapeutics|2024 Q1|33.69500887749063|6.777E8|185| |UTHR|UTHR.O|United Therapeutics|2024 Q2|19.849119865884326|7.149E8|185| |UTHR|UTHR.O|United Therapeutics|2024 Q3|22.891368559238597|7.489E8|185| |UTHR|UTHR.O|United Therapeutics|2024 Q4|19.716935090287947|7.359E8|185| 2. **Expense Trend**: There are no available data on UTHR's expenses for Q4 2024. The absence of this information makes it difficult to assess the company's overall financial health and profitability for the period.